Icatibant, another piece of the therapeutic puzzle regarding hemodynamic side effects of angiotensin-converting enzyme inhibitors
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Honore, Patrick M.
De Bels, David
Barreto Gutierrez, Leonel
Text and Data Mining valid from 2019-08-28
Version of Record valid from 2019-08-28
28 July 2019
16 August 2019
28 August 2019
Ethics approval and consent to participate
The authors declare that they have no competing interests.